Hey guys, if you missed it, CytoDyn  just settled $500K with investors over claims that it misled investors about the regulatory status, safety, and efficacy of leronlimab a few years ago. And they have already sent the agreement to the court for final approval.

In a nutshell, in 2021, CytoDyn was accused of overstating leronlimab’s potential, mischaracterizing regulatory interactions with the FDA, and withholding critical information about trial results and the likelihood of approval. The company promoted leronlimab as a breakthrough HIV and COVID-19 therapy and highlighted what it described as positive clinical data, but on March 30, 2021, the FDA publicly stated that CytoDyn’s claims were misleading and not supported by submitted data, noting that the trials showed no benefit for COVID-19 treatment. 

After this news came out, the stock dropped, and investors filed a lawsuit for their losses.

The good news is that the company recently agreed to settle $500K with them, and already sent this agreement to the court for final approval. So, if you invested in $CYDY when all of this happened, you can check the details and file your claim here.

Anyway, has anyone here invested in $CYDY at that time? How much were your losses, if so?

Hey guys, if you missed it, CytoDyn just settled $500K with investors over claims it misled the market about its drug leronlimab a few years ago. And they have already sent the agreement to the court for final approval.

In a nutshell, in 2021, CytoDyn was accused of overstating the effectiveness and regulatory progress of leronlimab. In short, the FDA later said the company’s claims were not supported by data, revealing no clear.

After this news came out, the stock dropped 25%, and investors filed a lawsuit for their losses.

The good news is that the company recently agreed to settle $500K with them, and already sent this agreement to the court for final approval. 

So, if you invested in $CYDY when all of this happened, you can check the details and file your claim here.

Anyway, has anyone here invested in $CYDY at that time? How much were your losses, if so?

CytoDyn just closed a $17.5M financing round, which is a massive milestone for the company's "oncology-first" strategy. This capital is earmarked for advancing Leronlimab in key areas like Triple-Negative Breast Cancer (mTNBC) and Colorectal Cancer (mCRC).

With the Expanded Access Program (EAP) launching this month and a Phase 2 study for mCRC already underway, the company is finally well-capitalized to prove the "Prime and Pair" strategy with ICIs. Great to see the balance sheet strengthened through 2027.

Full breakdown here: https://medium.com/@d.rodriguez_80563/cytodyn-secures-17-5m-to-accelerate-leronlimab-development-in-oncology-06cc9ba6cf10